Glucagon-related peptides in the mouse retina and the effects of deprivation of form vision

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 245, Issue 2, 2007, Pages 267-275

  Mathis, Ute ^a   Schaeffel, Frank ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Emmetropization; Glucagon; Mouse; Myopia; Retina

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON DERIVATIVE; GLUCAGON LIKE PEPTIDE 2; GROWTH HORMONE RELEASING FACTOR; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; PEPTIDE HISTIDINE ISOLEUCINE; SECRETIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYE DEVELOPMENT; IMMUNOFLUORESCENCE TEST; MOUSE; MYOPIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; RETINA; TISSUE LEVEL; VISION; WILD TYPE;

ANIMALS; DISEASE MODELS, ANIMAL; EARLY GROWTH RESPONSE PROTEIN 1; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDES; GROWTH HORMONE-RELEASING HORMONE; MICE; MICE, INBRED C57BL; MICROSCOPY, FLUORESCENCE; MYOPIA; PEPTIDE PHI; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RETINA; SENSORY DEPRIVATION; VASOACTIVE INTESTINAL PEPTIDE;

EID: 33847137721     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-006-0282-x     Document Type: Article

References (42)

1. Armstrong PE, Foy WL, Johnston CF, Shaw C, Murphy RF, Buchanan KD (1989) Peptide histidine isoleucine (PHI) immunoreactivity in the rat retina: identification and characterisation by radioimmunoassay, immunohistochemistry and high performance liquid chromatography. Regul Pept 25:325-332
2. Bitzer M, Schaeffel F (2002) Defocus-induced changes in Zenk expression in the chicken retina. Invest Ophthalmol Vis Sci 43:246-252
3. Brand C, Burkhardt E, Schaeffel F, Choi JW, Feldkaemper MP (2005) Regulation of Egr-1, VIP, and Shh mRNA and Egr-1 protein in the mouse retina by light and image quality. Mol Vis 11:309-320
4. Casini G, Molnar M, Brecha NC (1994) Vasoactive intestinal polypeptide/ peptide histidine isoleucine messenger RNA in the rat retina: Adult distribution and developmental expression. Neurosci 3:657-667
5. Cellerino B, Arango-González G, Pinzón-Duarte G, Kohler K (2003) Brain-derived neurotrophic factor regulates expression of vasoactive intestinal polypeptide in retinal amacrine cells. J Comp Neurol 467:97-104
6. Cho GJ, Ryu S, Kim YH, Cheon EW, Park JM, Kim HJ, Kang SS, Choi WS (2002) Upregulation of glucose-dependent insulinotropic polypeptide and its receptor in the retina of streptozotocin-induced diabetic rats. Curr Eye Res 6:381-388
7. Ekman R, Tornqvist K (1985) Glucagon and VIP in the retina. Invest Ophthalmol Vis Sci 26:1405-1409
8. Eriksen EF, Larsson L-I (1981) Neuropeptides in the retina: Evidence for differential topographical localization. Peptides 2:153-157
9. Feldkaemper MP, Schaeffel F (2002) Evidence for a potential role of glucagon during eye growth regulation in chicks. Vis Neurosci 19:755-766
10. Feldkaemper MP, Burkhardt E, Schaeffel F (2004) Localization and regulation of glucagon receptors in the chick eye and preproglucagon and glucagon receptor expression in the mouse eye. Exp Eye Res 79:321-329
11. Fernandez-Durango R, Sanchez D, Fernandez-Cruz A (1990) Identification of glucagon receptors in rat retina. J Neurochem 54:1233-1237
12. Fischer AJ, McGuire JJ, Schaeffel F, Stell WK (1999) Light- and focus-dependent expression of the transcription factor ZENK in the chick retina. Nat Neurosci 2:706-712
13. Grimm A, Wenzel F, Hafezi C, Reme E (2000) Gene expression in the mouse retina: The effect of damaging light. Mol Vis 6:252-260
14. Hannibal J, Ding JM, Chen D, Fahrenkrug J, Larsen PJ, Gilette MU, Mikkelsen JD (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP) in the retinohypothalamic tract: A potential daytime regulator of the biological clock. J Neurosci 17:2637-2644
15. Herbst H, Thier P (1996) Different effects of visual deprivation on vasoactive intestinal polypeptide (VIP)-containing cells in the retinas of juvenile and adult rats. Exp Brain Res 111:345-355
16. Hui H, Zhao X, Perfetti R (2005) Structure and function studies of glucagon-like peptide-1 (GLP-1): The designing of a novel pharmacological agent for the treatment of diabetes. Diabetes Metab Res Rev 21:313-331
17. Jaworski CJ, Tsai J-Y, John-Aryankalayil M, Cox C, Wawrousek E, Carper D (2005) Evidence for glucagon and GLP-2 in ocular tissues. Invest Ophthalmol Vis Sci 45 ARVO E-Abstract 5160
18. McBrien NA, Moghaddam HO, Reeder AP (1993) Atropine reduces experimental myopia and eye enlargement via a nonaccommodative mechanism. Invest Ophthalmol Vis Sci 34:205-215
19. Morgan IG, Rose KA (2005) How genetic is school myopia? Prog Retin Eye Res 24:1-38
20. Ohngemach S, Buck C, Simon P, Schaeffel F, Feldkaemper M (2004) Temporal changes of novel transcripts in the chicken retina following imposed defocus. Mol Vis 28:1019-1027
21. Ostrin LA, Frishman LJ, Glasser A (2004) Effects of pirenzepine on pupil size and accommodation in rhesus monkeys. Invest Ophthalmol Vis Sci 45:3620-3628
22. Pachter JA, Marshak DW, Lam DM, Fry KR (1989) A peptide histidine isoleucine/peptide histidine methionine-like peptide in the rabbit retina: Colocalization with vasoactive intestinal peptide, synaptic relationships and activation of adenylate cyclase activity. Neuroscience 2:507-519
23. Raviola E, Wiesel TN, Lamk SL, Chetri A (1991) Increase of retinal vasoactive intestinal polypeptide (VIP) after neonatal lid fusion in the rhesus macaque. Invest Ophthalmol Vis Sci 32 [Suppl]:1203
24. Saw SM, Gazzard G, Au Eong KG, Koh D (2003) Utility values and myopia in teenage school students. Br J Ophthalmol 87:341-345
25. Saw SM, Chua WH, Gazzard G, Koh D, Tan DT, Stone RA (2005) Eye growth changes in myopic children in Singapore. Br J Ophthalmol 89:1489-1494 1489-1494
26. Schaeffel F, Burkhardt E, Howland HC, Williams RW (2004) Measurement of refractive state and deprivation myopia in two strains of mice. Optom Vis Sci 81:99-110
27. Schmucker C, Schaeffel F (2004) In vivo biometry in the mouse eye with low coherence interferometry. Vision Res 44:2445-2456
28. Seki T, Shioda S, Nakai Y, Arimura A, Koide R (1998) Distribution and ultrastructural localization of pituitary adenylate cyclase-activating polypeptide (PACAP) and its receptor in the rat retina. Ann NY Acad Sci 865:408-411
29. Seki T, Shioda S, Izumi S, Arimura A, Koide R (2000) Electron microscopic observation of pituitary adenylate cyclase-activating polypeptide (PACAP)-containing neurons in the rat retina. Peptides 21:109-113
30. Sherwood NM, Krueckl SL, McRory JE (2000) The origin and function of the pituitary adenylate cyclase- activating polypeptide (PACAP) glucagon superfamily. Endocr Rev 21:619-670
31. Shih YF, Chen CH, Chou AC, Ho TC, Lin LL, Hung PT (1999) Effects of different concentrations of atropine on controlling myopia in myopic children. J Ocul Pharmacol Ther 15:85-90
32. Siatkowski RM, Cotter S, Miller JM, Scher CA, Crockett RS, Novack GD (2004) Safety and efficacy of 2% pirenzepine ophthalmic gel in children with myopia: A 1-year, multicenter, double-masked, placebo-controlled parallel study. Arch Ophthalmol 122:1667-1674
33. Stanke JJ, Fischer AJ (2005) Developmental of cholinergic amacrine cells in the chicken retina. Invest Ophthalmol Vis Sci 45 ARVO E-Abstract 559
34. Terubayashi H, Tsuto HT, Fukui K, Obata HL, Okamura H, Gujisawa H, Itoi M, Yanaihara C, Yanaihara N, Ibata J (1983) VIP (vasoactive intestinal polypeptide)-like immunoreactive amacrine cells in the retina of the rat. Exp Eye Res 36:743-749
35. Tigges M, Iuvone PM, Fernandes A, Sugrue MF, Mallorga PJ, Laties AM, Stone RA (1999) Effects of muscarinic cholinergic receptor antagonists on postnatal eye growth of rhesus monkeys. Optom Vis Sci 76:397-407
36. Tornqvist K, Uddman R, Sundler F, Ehinger B (1982) Somatostatin and VIP neurons in the retina of different species. Histochemistry 76:137-152
37. Truong HT, Cottrial CL, Gentle A, McBrien NA (2002) Pirenzepine affects scleral metabolic changes in myopia through a non-toxic mechanism. Ophthalmology 110:1069-1070
38. Unson CG, Cypess AM, Wu CR, Goldsmith PK, Merifield RB, Sakmar TP (1996) Antibodies against specific extracellular epitopes of the glucagon receptor block glucagon binding. Proc Natl Acad Sci USA 93:310-315
39. Vessey KA, Lencses KA, Rushforth DA, Hruby VJ, Stell WK (2005) Glucagon receptor agonists and antagonists affect the growth of the chick eye: A role for glucagonergic regulation of emmetropization? Invest Ophthalmol Vis Sci 46:3922-3931
40. Vessey KA, Rushforth DA, Stell WK (2005) Glucagon- and secretin-related peptides differentially alter ocular growth and the development of form-deprivation myopia in chicks. Invest Ophthalmol Vis Sci 46:3932-3942
41. Zadnik K, Mutti DO (2003) Darkness and myopia progression. Ophthalmology 110:1069-1070
42. Zhong X, Ge J, Smith EL III, Stell WK (2004) Image defocus modulates activity of bipolar and amacrine cells in macaque retina. Invest Ophthalmol Vis Sci 45:2065-2074